Earnings History Data for Innate Pharma S.A. (IPHA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Innate Pharma S.A.

Innate Pharma S.A. is a commercial stage oncology-focused biotech company. It discovers and develops therapeutic antibodies for the treatment of cancer. The company's commercial-stage product includes Lumoxiti. Innate Pharma S.A. is based in Marseille, France.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
21-03-2024 PM IPHA Innate Pharma S.A. 190.11 N/A 0.00 0.00 Innate Pharma GAAP EPS of -€0.09, revenue of €61.64M
[3/21/2024 5:21 AM]
2.41 -0.09 
(-3.60%)
2.41 -0.09 
(-3.60%)
1.81 - 3.57 10,172 10,000 1,264
14-11-2023 PM IPHA Innate Pharma S.A. 188.52 N/A 0.00 0.00 Innate Pharma reports results for the first nine months
[11/14/2023 2:33 AM]
2.58 0.31 
(13.66%)
0.0 0.0 
(0.00%)
1.81 - 3.97 29,565 30,000 0
23-03-2023 PM Before the open
(Mar 23)
IPHA Innate Pharma S.A. 247.05 N/A 0.00 0.00 Innate Pharma GAAP EPS of -€0.73, revenue of €57.67M
[3/23/2023 2:21 AM]
2.95 -0.08 
(-2.64%)
0.0 0.0 
(0.00%)
1.90 - 3.97 4,252 20,000 0
24-03-2022 PM IPHA Innate Pharma S.A. 267.03 N/A 0.00 0.00 Innate Pharma GAAP EPS of -€0.66, revenue of €24.7M
[3/24/2022 2:33 AM]
3.29 -0.18 
(-5.19%)
3.39 -0.08 
(-2.31%)
2.66 - 11.95 11,581 41,121 0
11-05-2021 PM Before the open
(May 11)
IPHA Innate Pharma S.A. 312.04 N/A 0.00 0.00 Innate Pharma reports Q1 results
[5/11/2021 3:46 AM]
4.04 0.18 
(4.66%)
4.07 0.21 
(5.44%)
3.55 - 8.23 3,262 0 865